- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Transabdominal ultrasound.
Displaying page 1 of 1.
EudraCT Number: 2022-001710-19 | Sponsor Protocol Number: LUMINALSONAZOID001 | Start Date*: 2022-11-01 |
Sponsor Name:Medical department, Haukeland University Hospital | ||
Full Title: Sonographic diagnostics with oral contrast for Crohns. A novel method for detecting Crohns disease using sonographic intraluminal contrast. | ||
Medical condition: Crohns disease in the terminal ileum | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005865-37 | Sponsor Protocol Number: PIL-629-WEB-0128-I | Start Date*: Information not available in EudraCT |
Sponsor Name:Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan | ||
Full Title: Levofloxacin vs Piperacillin/Sulbactam and Sultamicillin in patients with acute cholecystitis. A double blind, randomized study. | ||
Medical condition: acute cholecystitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003245-29 | Sponsor Protocol Number: SA652013 | Start Date*: 2016-12-19 |
Sponsor Name:Amsterdam AMC, locatie AMC | ||
Full Title: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy | ||
Medical condition: Prevention of symptomatic gallstone disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004258-77 | Sponsor Protocol Number: CM-101-PSC-001 | Start Date*: 2019-02-05 | |||||||||||
Sponsor Name:ChemomAb Ltd. | |||||||||||||
Full Title: A Phase 2, Open Label, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of CM-101 Administered for 12 Weeks in Adult Subjects with Primary Sclerosing Cholangitis. | |||||||||||||
Medical condition: Treatment of Primary Sclerosing Cholangitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003727-27 | Sponsor Protocol Number: MVT-601-3001 | Start Date*: 2017-06-12 | ||||||||||||||||
Sponsor Name:Myovant Sciences GmbH c/o Vischer AG | ||||||||||||||||||
Full Title: LIBERTY 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co Administered with and without Low-Dose Estradiol and Norethindron... | ||||||||||||||||||
Medical condition: heavy menstrual bleeding associated with uterine fibroids | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-005113-50 | Sponsor Protocol Number: MVT-601-3002 | Start Date*: 2017-05-22 | ||||||||||||||||
Sponsor Name:Myovant Sciences GmbH | ||||||||||||||||||
Full Title: LIBERTY 2: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co Administered with and without Low-Dose Estradiol and Norethindron... | ||||||||||||||||||
Medical condition: heavy menstrual bleeding associated with uterine fibroids | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-004338-26 | Sponsor Protocol Number: FE200486 CS28 | Start Date*: 2008-11-18 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: Ensayo clínico abierto, aleatorizado, de grupos paralelos que compara degarelix frente a bloqueo androgénico combinado (goserelina + bicalutamida) en términos de reducción de la puntuación en la es... | |||||||||||||
Medical condition: Cáncer de próstata | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: ES (Completed) GB (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
